1M6MYTD1Y5YMAX
Loading quotes...
Core data
| Name | VanEck Genomics and Healthcare Innovators ETF |
| Issuer | VanEck |
| Fund domicile | Ireland |
| TER | 0.35% |
| Fund size | €15.42M |
| P/E ratio | 29.78 |
| P/B ratio | 5.31 |
| Inception date | 09/02/2022 |
| Website |
Deep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
XETRA | CURE.DE |
Düsseldorf | CURE.DU |
Frankfurt | CURE.F |
London | CURE.L |
Milan | CURE.MI |
SIX | CURE.SW |
München | CURE.MU |
Hamburg | CURE.HM |
Composition
| Holdings | Share |
|---|---|
| 11.27% | |
| 8.17% | |
| 7.64% | |
| 7.50% | |
| 7.19% | |
| 6.30% | |
| 4.76% | |
| 4.22% | |
| 3.60% | |
| 3.47% |
As of 09/01/2026
Top sectors
| Sector | Share |
|---|---|
Health Care | 93.01% |
Consumer Staples | 6.55% |
Top countries
| Country | Share |
|---|---|
USA | 88.62% |
China | 4.47% |
Australia | 2.34% |
Japan | 1.43% |
Switzerland | 1.36% |
Sweden | 0.99% |
United Kingdom | 0.41% |
Netherlands | 0.38% |
Discover assets
Shareholders of VanEck Genomics and Healthcare Innovators ETF also invest in the following assets
